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We think of pain as a symptom. But in . . . patients [with chronic pain], the pain is the 
disease. 
—Clifford J. Woolf, director of the F.M. Kirby Neurobiology Center at 
Boston Children’s Hospital and neurology professor at Harvard Medical 
School1    
 
INTRODUCTION 
Shortly before receiving yet another lidocaine needle in the back of his neck, Staff Sergeant 
Josh Kisner, an Army veteran who suffers from severe headaches and chronic neck pain, 
confessed:  
I don’t know why it is starting up again.  It had calmed down to a tolerable level.  It’s the 
stupidest things like reaching into the closet to grab a shirt.  For a while, I just lived on 
 
1 Lenny Bernstein, For some with chronic pain, the problem is not in their backs or knees but their brains, WASH. 
POST (Sept. 23, 2019, 7:26 PM), https://www.washingtonpost.com/national/health-science/for-some-with-chronic-
pain-the-problem-is-not-in-their-backs-or-knees-but-their-brains/2019/09/23/80538660-5d5c-11e9-842d-
7d3ed7eb3957_story.html.  See also OWEN D. JONES ET AL., LAW AND NEUROSCIENCE 344 (2014).   
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Percocets. It was the only way to do it.  That’s why I hate that drug and if they give it to 
me after surgery, I am going to beg for something else.2   
This was just another day “along recovery” for Kisner, who avoided medical evacuation despite 
experiencing symptoms of traumatic brain injury (“TBI”), while deployed in Baqubah, Iraq in 
2007.3  Fellow Army veteran Justin Springer made Kisner’s story accessible to the public through 
his documentary, Along Recovery, which bravely and respectfully follows four wounded soldiers 
whose lives changed dramatically after returning from Iraq and Afghanistan and captures their 
treatment experiences at Brooke Army Medical Center in San Antonio, Texas.4  Springer describes 
the health conditions faced by soldiers returning from overseas combat deployments: severe 
headaches, chronic pain, sleeplessness, depression, and memory and concentration issues, among 
others.5  It is frustrating because “you can have all these problems but there’s no real way to 
pinpoint why you are having them.”6  When doctors give soldiers an MRI, “it almost always comes 
back negative and they can’t really see why you are having any problems.”7    
As Sean Hollins, a soldier suffering from a TBI explained, he would contemplate 
withholding how he felt from the hospital because “they say[,] hey[,] let’s give you some more 
medication,”8 and he is “not a big fan of medications.”9  The initial instinct of doctors to prescribe 
to soldiers opioids as part of their treatment plan, without more, leads to opioid misuse and 
 
2 Along Recovery, (Gravitas Ventures May 20, 2012), https://www.amazon.com/Along-Recovery-Justin-
Springer/dp/B00GDF77AM. 49:11-49:40. 
3 Along Recovery, supra note 2, at 17:10-17:16.  
4 Id. at 17:10-17:16. 
5 Id. at 20:28-20:56. 
6 Id. at 20:28-20:56. 
7 Id. at 20:28-20:56. 
8 Id. at 28:00-28:32. 
9 Id. at 30:50-31:02. 
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addiction.10  This sad reality highlights how the treatment process affects people suffering from 
chronic pain and comorbid conditions.11  Witnessing how these soldiers struggled through 
Springer’s eye-opening documentary footage frames the need to re-assess the current treatment 
protocols for the disease of chronic pain.   
This paper argues that there is a disconnect between our understanding of chronic pain and 
the legal infrastructure surrounding treatment of the disease. The healthcare delivery system 
currently limits or denies patients access to evidence-based alternatives that demonstrably alleviate 
chronic pain. This paper proceeds as follows. Part I provides a brief overview of the addicted brain 
and the opioid crisis and explains how these topics connect with chronic pain. Part II examines the 
efficacy of evidence-based treatment methods, existing guidelines on chronic pain treatment, and 
the importance of integrating alternative treatment methods into a pain patient’s multidisciplinary 
treatment plan.  It then addresses problems under current law, including the lack of insurance 
coverage for evidence-based alternative pain treatments. Part III proposes legal reforms to bridge 
these gaps. Specifically, it recommends that the Department of Health and Human Services 
(“HHS”) condition state funding for chronic pain—in connection with opioid-related funding—on 
state medical boards’ implementation of a mandated 15-week evidence-based alternative treatment 
plan in place of opioid therapy or, where medically necessary, in conjunction with prescription 
 
10 See Jennifer D. Oliva, Son of Sam, Service-Connected Entitlements, and Disabled Veteran Prisoners, 25 GEO. 
MASON L. REV. 302, 303 n.7 (2018) (citing sources that reference veterans facing addiction, including Andrew Golub 
& Alexander S. Bennett, Introduction to the Special Issue: Drugs, Wars, Military Personnel, and Veterans, 48 
SUBSTANCE USE & MISUSE 795, 796 (2013)). 
11 Josh Roe, One veteran tells the story of his struggles trying to manage chronic pain, ABC NEWS CHANNEL (Sept. 
11, 2019), https://newschannel9.com/features/price-of-freedom/one-veteran-tells-the-story-of-his-struggles-trying-
to-manage-chronic-pain (describing veteran Scott McConathy struggles because for 12 years doctors gave him 60 mg 
of Morphine 3 times per day, lowered to 40 milligrams of hydrocodone, then cut him off). 
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opioids. It further contends that HHS ought to require evidence of protocols implementing 
individualized plans that integrate any combination of sessions in therapies including, but not 
limited to, cognitive behavioral therapy, yoga, acupuncture, and physical therapy. In additional, 
federal law should require insurance companies to cover these evidence-based alternatives.   
Part IV examines some potential problems that could result from the solutions proposed in 
Part III. Those include the additional demands required of doctors and other practitioners treating 
patients for pain, namely focusing additional time and resources on these patients, as well as 
demands on insurance companies that have thus far failed to provide coverage for alternatives. 
Part IV responds to these concerns and the resistance to change in several ways. It argues that: (i) 
chronic pain already costs our country because people are suffering and dying from the misuse of 
opioids; (ii) this country has spent billions of dollars on this public health crisis already with limited 
progress; (iii) the cost of alternative treatments is not measurable without attempting to effectively 
implement a program to fill the known gaps in chronic pain treatment; and (iv) these alternatives 
are cost- and resource-effective. This paper concludes by reiterating the need for mandatory, 
individualized evidence-based alternative treatment plans for chronic pain patients.  
I. BACKGROUND 
A. The U.S. Opioid Misuse and Overdose Public Health Crisis: Brain Effects 
and Relevant Statistics 
The United States is facing a substance use disorder and drug overdose public health 
crisis.12  In the United States, over 130 people die each day after overdosing on opioids according 
 
12 Puja Seth et al., Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants — United States, 2015–
2016, 67 MORBIDITY & MORTALITY WKLY. REP. 1, 1 (2018). 
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to the National Institute of Health (“NIH”).13 In 2017, opioid use disorder resulted in 47,600 drug-
overdose deaths.14  Advances in neuroscience show the effects of drugs on neural pathways and 
differences in brain-wiring between people suffering from opioid use disorder and those that do 
not.15 The CDC published opioid prescribing guidelines in 2016, which recommend dosage 
limitations and the satisfaction of certain threshold requirements prior to prescription renewal.16 
While the guidelines are useful, there was controversy surrounding their implementation17 and 
they are insufficient standing alone. Neuroscience research demands a change in our approach to 
treating the underlying disease of pain due to its effects on brain circuitry and quality of life. If we 
intend to overcome the opioid crisis, it is critical that we reassess our view of the addicted brain, 
especially in the context of chronic pain. 
B. The connection between chronic pain and opioid use disorder 
Chronic pain and opioid use disorder are interrelated.  The Institute of Medicine Report on 
Pain (“IOM Report”) suggests that 100 million Americans suffer from pain.18 “The medical 
 
13 NATIONAL INSTITUTE ON DRUG ABUSE, Opioid Overdose Crisis, https://www.drugabuse.gov/drugs-
abuse/opioids/opioid-overdose-crisis (last visited Nov. 21, 2019). 
14 See U.S. DEP’T OF HEALTH & HUMAN SERVS., CTRS. FOR DISEASE CONTROL & PREVENTION, Overview of the Drug 
Overdose Epidemic: Behind the Numbers, https://www.cdc.gov/drugoverdose/data/ (last visited Nov. 12, 2019). 
(citing Lawrence Scholl et al., Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017, 67 
MORBIDITY & MORTALITY WKLY. REP. 1419, 1419 (2019)). 
15 Alan I. Leshner, Addiction is a Brain Disease, and It Matters, 278 SCIENCE 45, 45 (1997), in OWEN D. JONES ET 
AL., LAW AND NEUROSCIENCE 592 (2014).   
16 Deborah Dowell et al., CDC Guideline for Prescribing Opioids for Chronic Pain, 65 MORBIDITY & MORTALITY 
WKLY. REP. 1, 30 (2016), 
https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2F
mmwr%2Fvolumes%2F65%2Frr%2Frr6501e1er.htm. 
17 See infra notes 74-76 and accompanying text. 
18 Position Statement, American Academy of Pain Medicine, Use of Opioids for the Treatment of Chronic Pain (Mar. 
7, 2013), https://painmed.org/about/position-statements/use-of-opioids-for-the-treatment-of-chronic-pain (citing 
Institute of Medicine, Committee on Advancing Pain Research, Care and Education, Relieving Pain in America: A 
Blueprint for Transforming Prevention, Care, Education, and Research, WASHINGTON (DC): NATIONAL ACADEMIES 
PRESS (US) (2011) [hereinafter IOM REPORT]). 
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blunder of casually prescribing opioids for acute and chronic pain is partly to blame for the 
addiction crisis that has taken more than 400,000 lives over the past 20 years.”19  Many who suffer 
from chronic pain are either not receiving adequate treatment or relying on opioids.20  Critically, 
the relief from opioids is temporary, so opioids are not effective at managing patients’ pain.21  
When the opioids wear off, the pain becomes prevalent.22  This, in turn, causes pain to affect 
patients like a debilitating disease, resulting in the patient’s need for more opioids and ongoing 
dependency, with limited relief.23  Change is on the horizon, but before this paper discusses current 
developments, it provides some background on chronic pain and the legal framework. 
C. The law’s understanding of chronic pain and the disconnect reflected by 
legal framework 
Chronic pain is pain that persists past the end of the injury-related healing process, which 
differentiates chronic pain from acute pain.24 Chronic pain generally is pain that lasts more than 
three months.25 Pain results from neurological changes, affecting the central nervous system and 
peripheral nerves; it does not have to be the product of something else.26  In other words, “you can 
have an injury that heals and still have pain [or] you can have no specific injury and have pain . . . 
 
19 See Bernstein, supra note 1, at 1 (observing that casually prescribing opioids plays a role in opioid-related deaths). 
20 Puja Seth et al., supra note 11, at 1. 
21 Id. at 1. 
22 Id. at 1. 
23 Matt Seidholz & Allison Young, Can Cognitive Behavioral Therapy Help Reduce Pain Better Than Opioids?, 
EVERYDAY HEALTH (Nov. 21, 2018), https://www.everydayhealth.com/opioids/can-cognitive-behavioral-therapy-
help-reduce-pain-better-than-opioids/. 
24 OWEN D. JONES ET AL., LAW AND NEUROSCIENCE 344 (2014).   
25 Jennifer L. Murphy et al., Cognitive behavioral therapy for chronic pain among veterans: Therapist manual 11, 
U.S. DEPARTMENT OF VETERANS AFFAIRS, https://www.va.gov/PAINMANAGEMENT/docs/CBT-
CP_Therapist_Manual.pdf (last visited Nov. 21, 2019). 
26 Amanda C. Pustilnik, Address at the Mass General Hospital Center for Law, Brain & Behavior Public Symposium: 
The Pain Brain in Evidence and Policy—Visible Solutions: How Neuroimaging Helps Law Re-Envision Pain (June 
30, 2015).  
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[The pain] is in the brain.” 27  Chronic pain, as experienced by an individual, results from a 
combination of physical, psychological, and environmental factors, and thus pain is subjective and 
difficult to quantify objectively.28   
The law relies on an outdated conceptualization of pain, which affects the evaluation of 
pain and legal compensation for it. Carradine v. Barnhart depicts chronic pain and how courts 
historically have approached pain.29  Here, Carradine slipped and fell and her pain endured.30 The 
court denied her request for disability benefits, finding a lack of “objective evidence” to support 
her alleged pain.31  The appellate court reversed, reasoning that back surgery and taking painkillers 
were objective measures she took to lessen her pain.32  However, the court went on to point to the 
psychosomatic aspect of her pain, by proclaiming that her back was fine, and her complaints show 
that the pain is all “in her head.”33  Such reasoning demonstrates the law’s lack of understanding 
of pain and its effect on the framework for providing relief for pain patients.34   
Law professor Amanda C. Pustilnik pointed out the abovementioned holes in the legal 
analysis in Carradine.35 She poignantly noted that “the Social Security Administration said in 1984 
that they wanted to reconsider their pain reg[ulations], and we are still in the same place.  It might 
be easier to reach judges and change the law interstitially through interpretation.”36  This paper 
 
27 Id. at 10:26-10:30 (emphasis added). 
28 Daniel J. Gabler, Conscious Pain and Suffering Is Not a Matter of Degree, 74 MARQ. L. REV. 289, 296 (1991).  
29 See Carradine v. Barnhart, 360 F.3d 751 (7th Cir. 2004).   
30 Id. at 753. 
31 Id. at 751. 
32 Id. at 754. 
33 Id. at 754. 
34 Pustilnik, supra note 25, at 03:15-04:02. 
35 Id. at 05:05-08:28. 
36 Id. at 50:48-51:38. 
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argues that it is beyond time to make such changes, but it is important to take a look at the research 
on evidence-based alternatives prior to delving into that discussion. 
II. THE EVIDENCE-BASED ALTERNATIVES AND MULTIDISCIPLINARY 
TREATMENT PLAN CHRONIC PAIN PATIENTS DESERVE FOR 
TREATING THEIR DISEASE 
Studies on non-pharmacological alternatives for treatment of chronic pain repeatedly deem 
such treatment methods effective.37 This section looks at broad studies and trends and then delves 
into specific research that demonstrates the efficacy of cognitive behavioral therapy, physical 
therapy, and acupuncture as examples of the need for implementation of evidence-based 
alternatives. It then chronicles several recent recommendations to treat pain patients with evidence-
based treatment alternatives to opioids, the need for a multidisciplinary patient-centric 
individualized treatment plan, problems under current law (including lack of insurance coverage 
for evidence-based alternatives), and findings from brain imaging related to chronic pain. 
A. Studies on the efficacy of evidence-based alternatives 
Studies exploring evidence-based alternatives for treatment of chronic pain demonstrate 
the effectiveness of such alternative treatments in improving patient outcomes, with an important 
caveat—that certain evidence-based alternatives work better than others for specific chronic pain 
conditions.38 One 2007 study explored the effectiveness of chiropractic, meditation, hypnosis, 
yoga, biofeedback, and acupuncture in treating chronic pain.39 It suggests that these alternative 
 
37 Luca Scascighini et al., Multidisciplinary treatment for chronic pain: a systematic review of interventions and 
outcomes, 47 RHEUMATOLOGY 1, 11 (2008). 
38 Andrea C. Skelly et al., Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review, 209 
AGENCY FOR HEALTHCARE RESEARCH & QUALITY  1, 40 (2018), https://www.ncbi.nlm.nih.gov/books/NBK519958/.  
39 Gabriel Tan et al., Efficacy of selected complementary and alternative medicine interventions for chronic pain, 44 
J. REHAB. RESEARCH & DEV. 195, 195 (2007). 
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treatment modalities have varying levels of efficacy, and clinicians should become familiar with 
these non-pharmacological methods and consider incorporating them into treatment plans.40   
Separately, trends became apparent in soldiers, who suffered from injuries in training or in 
combat.  As a result of injuries, soldiers experienced tremendous pain, compounded by PTSD and 
traumatic brain injury, and sadly, they showed little response to the treatment methods health care 
practitioners implemented.41  Due to a high rate of psychological illnesses, suicide, drug and 
alcohol addiction, the Army Surgeon General’s Pain Management Task Force (“PMTF”) came 
about in 2009 to create a “comprehensive pain management strategy that was holistic, multi-
disciplinary and multi-modal in its approach.”42  The PMTF published a formal report in 2010, 
which included over 100 recommendations for practice, education, research, and organizational 
changes at all levels.43 The abovementioned IOM Report followed.44 Both reports recommended 
and endorsed evidence-based alternatives for pain patients and a patient-centered, multimodal 
treatment plan.45 The next section examines the efficacy of specific evidence-based alternatives to 
prescription opioids—cognitive behavioral therapy, physical therapy, and acupuncture. 
1. Efficacy of Cognitive Behavioral Therapy for chronic pain 
Cognitive Behavioral Therapy (“CBT”) is a form of psychotherapy focused on present 
circumstances and emotions and uprooting negativity.46  In the context of chronic pain, successful 
 
40 Id. at 208. 
41 Eric Schoomaker & Chester Buckenmaier, Call to Action: ‘If Not Now, When? If Not You, Who?’, 15 PAIN MEDICINE 
S4, S5 (2014). 
42 Id. at S5. 
43 Id. at S5. 
44 See Schoomaker & Buckenmaier, supra note 40, at S5; IOM REPORT, supra note 17, at 93. 
45 Id. at S5. 
46 David A. Hanscom et al., Defining the Role of Cognitive Behavioral Therapy in Treating Chronic Low Back Pain: 
An Overview 5 GLOB. SPINE J. 496, 496 (2015).  
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CBT helps patients recognize the role that negative emotions and cognition play in influencing 
pain perception and recategorize pain by viewing it as a brain state, whereby the patient sees herself 
or himself as a well person who has pain.47  CBT decreases the individual’s obsession with pain, 
his or her constant urge for medical help, and, thereby, assists patients in managing their diseases.48   
Studies show that CBT improves chronic pain.49  One study compared patients with chronic 
pain to a healthy control group.50  The results established that, “[a]fter 11 weeks of CBT, patients 
with chronic pain had gray-matter volumes in the bilateral dorsolateral prefrontal, posterior 
parietal, anterior cingulate, and orbitofrontal and sensorimotor cortices similar to those found in a 
healthy control group.”51 This study showed tremendous implications for the impact of CBT on 
chronic pain, particularly through the evidence that neural pathways modified by pain can be 
uncoupled when pain begins to subside and patients begin to conceptualize pain differently.52   
A 2012 Cochrane Database Systemic Review found that CBT had “small to moderate 
positive effects on pain, disability, and mood immediately after treatment compared with treatment 
as usual.”53 Other reviews of CBT supported that finding, demonstrating that the treatment helps 
with both pain and depression.54 A randomized clinical trial found that patients who participated 
 
47 Id. at 497. 
48 Murphy, supra note 24, at 26. 
49 Id. at 10. 
50 David A. Seminowicz et al., Cognitive behavioral therapy increases prefrontal cortex gray matter in patients with 
chronic pain, 14 J. PAIN 1, 5 (2013), 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874446/pdf/nihms532417.pdf. 
51 Id. at 2. 
52 Id. at 6. 
53 Amanda Williams et al., Psychological therapies for the management of chronic pain (excluding headache) in 
adults, 11 COCHRANE DATABASE SYSTEMATIC REVIEW 1, 2 (2012), 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483325/pdf/CD007407.pdf. 
54 Dawn M. Ehde et al., Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and 
directions for research, 69 AM. PSYCHOLOGIST 153, 159 (2014). 
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in CBT or other mindfulness-based therapy had better outcomes after 26 weeks than those who 
did not receive these treatments.55  A study conducted by a team at Group Health Research Institute 
in Seattle compared different chronic low back pain treatment methods and concluded that 8 weeks 
of CBT can improve back pain over 6 months.56 Thus, research suggests that CBT can improve 
outcomes in patients with chronic pain. 
2. How Physical therapy can effectively alleviate chronic pain 
Physical therapy (“PT”) utilizes exercises and physical manipulation to preserve, restore, 
and improve range of motion and physical function after impairment caused by an injury, disease, 
or disability.57  Physical therapy has benefits for certain types of chronic pain patients, including 
some who take prescription opioids.58  However, insurance companies routinely place limitations 
on the number of PT visits and reimbursement, and this interferes with treatment efficacy.59   
Physical therapy is an integral component of chronic pain treatment; it helps improve 
physical functionality and quality of life by enhancing a patient’s ability to engage in various 
 
55 Daniel C. Cherkin et al., Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care 
on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial, 315 THE J. 
OF THE AM. MED. ASS’N 1, 8 (2016), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914381/pdf/nihms781082.pdf. 
56 Harrison Wein, Meditation and cognitive-behavioral therapy ease low back pain, NATIONAL INSTITUTES OF HEALTH 
(Mar. 29, 2016), https://www.nih.gov/news-events/nih-research-matters/meditation-cognitive-behavioral-therapy-
ease-low-back-pain (citing Daniel C. Cherkin et al., supra note 54, at 8 (2016)).  
57 Physical Therapy Definition, Merriam-Webster Dictionary, available at https://www.merriam-
webster.com/dictionary/physical%20therapy.  
58 Per the CDC press release following misapplication of the guidelines, these evidence-based alternatives are not 
appropriate as the front-line approach for conditions like oncology and terminal illnesses.  See Press Release, 
Centers for Disease Control and Prevention, CDC Advises Against Misapplication of the Guideline for Prescribing 
Opioids for Chronic Pain (Apr. 24, 2019), https://www.cdc.gov/media/releases/2019/s0424-advises-misapplication-
guideline-prescribing-opioids.html [hereinafter CDC PRESS RELEASE]. 
59 Erik Carvalho et al., Insurance Coverage, Costs, and Barriers to Care for Outpatient Musculoskeletal Therapy and 
Rehabilitation Services, 78 N.C. MED. J. 1, 1 (2018). 
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activities.60 A JAMA Network Open study observed patients experiencing pain in four categories 
(back, knee, neck, or shoulder pain).61  This study analyzed outcomes of 88,985 patients with 
private insurance who either received PT within 90 days of their initial doctor visit or did not 
receive such PT treatment.62  The data, collected at 91 and 365 days, found that a visit to a physical 
therapist early on can eliminate patients’ need for opioids and reduce the number of pills for those 
who do need to take prescription opioids for all 4 conditions assessed.63 Thus, the benefits of 
physical therapy for chronic pain are clear and widely recognized. 
3. Acupuncture as an efficacious treatment for chronic pain  
Acupuncture helps chronic pain more than traditional treatment methods, according to 
studies.64 Acupuncture involves stimulating specific points on the body by techniques, including 
insertion of thin metal needles through the skin.65 Ten million acupuncture treatments are 
administered in the United States annually.66  Three million American adults receive acupuncture 
each year; chronic pain is the leading reason for treatment.67 Acupuncture’s analgesic effect can 
happen almost immediately for pain patients, but the mechanism for how it works is unclear.68   
 
60 Eric Sun et al., Association of Early Physical Therapy With Long-term Opioid Use Among Opioid-Naive Patients 
With Musculoskeletal Pain, 1 THE J. OF THE AM. MED. ASS’N NETWORK OPEN 1, 7 (2018). 
61 Id. at 1. 
62 Id. at 3. 
63 Id. at 6. 
64 Dionysios Trigkilidas, Acupuncture therapy for chronic lower back pain: a systematic review, 29 ANNALS OF THE 
ROYAL C. OF SURGEONS OF ENGLAND, 595, 596  (2010). 
65 Mayo Clinic, ACUPUNCTURE, https://www.mayoclinic.org/tests-procedures/acupuncture/about/pac-20392763 (last 
visited Nov. 21, 2019). 
66 Jason Jishun Hao & Michele Mittelman, Acupuncture: Past, Present, and Future, 3 GLOB. ADVANCES IN HEALTH 
AND MED. 6, 6 (2014).   
67 Andrew J. Vickers et al., Acupuncture for chronic pain: individual patient data meta-analysis, 172 ARCHIVES OF 
INTERNAL MED. 1444, 1444 (2012). 
68 Kenji Kawakita & Kaoru Okada, Acupuncture therapy: mechanism of action, efficacy, and safety: a potential 
intervention for psychogenic disorders?, 8 BIOPSYCHOSOCIAL MED. 1, 2 (2014). 
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In a systematic review with meta-analysis, acupuncture was associated with greater, 
immediate relief of chronic pain compared to sham acupuncture or analgesic injection.69  In a meta-
analysis on the long-term impact of acupuncture, 90% of acupuncture benefits persisted 12-months 
after the conclusion of the course of treatment.70 Another study conducted by researchers from the 
University of York and Hull York Medical found that acupuncture impacts particular neural 
structures.71 Their research showed that acupuncture “deactivates” brain areas associated with 
processing pain.72  The many studies and reviews show that acupuncture reduces chronic pain. 
B. How efficacy of evidence-based alternatives has led to changes in guidelines 
and the clinical framework 
1. CDC Guidelines and their recommendation of using non-opioids to 
treat chronic pain 
The efficacy of non-pharmacological evidence-based alternatives in comparison with 
opioids has resulted in changes to guidelines for clinicians.73 The Centers for Disease Control and 
Prevention (“CDC”) released guidelines that recommend non-drug approaches as the preferred 
treatment methods for chronic pain and use of non-opioids over opioids.74  Opioids should only be 
used (i) in combination with non-pharmacological evidence-based alternatives, and (ii) if the 
“expected benefits for both pain and function are anticipated to outweigh risks to the patient.”75 
 
69 Anfeng Xiang et al., The Immediate Analgesic Effect of Acupuncture for Pain: A Systematic Review and Meta-
Analysis, 2017 EVIDENCE-BASED COMPLEMENTARY & ALTERNATIVE MED. 1, 4 (2017). 
70 Hugh MacPherson & Emily A. Vertosick, The persistence of the effects of acupuncture after a course of treatment: 
a meta-analysis of patients with chronic pain, 158 PAIN 1, 11 (2017), 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393924/.  
71 Aziz Asghar et al., Acupuncture needling sensation: the neural correlates of deqi using fMRI, 1315 BRAIN 
RESEARCH 111, 111 (2010). 
72 Id. at 111. 
73 Dowell et al., supra note 15, at 11. 
74 Centers for Disease Control and Prevention, GUIDELINES FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN, 
https://www.cdc.gov/drugoverdose/pdf/guidelines_factsheet-providers-a.pdf (last visited Nov. 21, 2019). 
75 Id. at 1. 
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The CDC explicitly notes that different evidence-based alternative treatments improve 
functionality, and the benefits last from 2 weeks to 6 months.76 Due to controversy surrounding 
physician practices attributed to the guidelines that were inconsistent with its recommendations, 
the CDC released commentary highlighting that the guidelines are not a one-size-fits-all approach 
and, thus, not appropriate for patients with conditions where opioids are medically necessary, such 
as active cancer, sickle cell disease, and post-surgical pain.77 The commentary also warned 
prescribers about the dangers of tapering patients off opioids too abruptly and applying the dosage 
guidelines improperly.78 The guidelines recommend integrating non-pharmacological evidence-
based alternatives,79 but do not require such treatment for any particular length of time.  
2. The Pain Management Best Practices Inter-Agency Task Force Report 
and its findings on gaps and recommendations   
As a result of 2016 federal legislation enacted in response to the opioid crisis, 
representatives from the Departments of Health and Human Services, Veterans Affairs, and the 
Department of Defense joined forces to create the Pain Management Best Practices Inter-Agency 
Task Force (“Pain Management Task Force”).80  The Pain Management Task Force released a 
report with recommendations and guidelines for treatment of chronic pain on May 9, 2019.81  The 
report emphasizes the critical role of alternative treatment methodologies for chronic pain and 
 
76 Dowell et al., supra note 15, at 7. 
77 Id. at 29. 
78 Id. at 13. 
79 Id. at 11. 
80 Comprehensive Addiction and Recovery Act of 2016, Pub. L. No. §114-198, 130 Stat. 695. 
81 See generally PAIN MANAGEMENT BEST PRACTICES INTER-AGENCY TASK FORCE, U.S. DEPARTMENT OF HEALTH 
AND HUMAN SERVICES, PAIN MANAGEMENT BEST PRACTICES INTER-AGENCY TASK FORCE REPORT: UPDATES, GAPS, 
INCONSISTENCIES, AND RECOMMENDATIONS (2019) [hereinafter TASK FORCE REPORT]. 
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recommended physical therapy and occupational therapy, among others.82 The Task Force also 
identified barriers to access to care, lack of understanding of these alternative therapies for pain by 
both patients and clinicians, and recommended investments in research to help providers 
incorporate these therapies into multidisciplinary treatment plans.83 The report further focused on 
reimbursement, recommending that Medicare, Medicaid, and private payers “develop appropriate 
reimbursement policies; . . . minimize insurance coverage delays; restore reimbursement to 
nonhospital sites of service to improve access; and, lower the cost of interventional procedures.”84   
Agencies and Congress started to look at the Task Force’s report and recommendations.85   
As the next section of this paper describes the funding that will help create change, it is important 
to remember that one element—a mandatory component implementing evidence-based treatment 
methods for chronic pain—is still missing. 
3. National Institutes of Health funding initiatives as a step toward change 
On September 26, 2019, the National Institutes of Health (“NIH”) awarded $945 million 
in funding across 41 states to support efforts to treat chronic pain through non-addictive methods, 
 
82 Id. at 21. 
83 Id. at 62. 
84 Id. at 37. 
85 For example, under Section 6032 of the Substance Use Disorder Prevention the Promotes Opioid Recovery and 
Treatment for patients and Communities Act (“SUPPORT Act”), HHS’s Secretary works with the Pain Management 
Task Force to develop an Action Plan to prevent opioid addiction and enhance access to medication-assisted 
treatment.  As part of CMS efforts to implement Section 6032, they sent the American Pharmacists Association 
(“APhA”) a request for information to help with the development of a Center for Medicare & Medicaid Services 
(“CMS”) action plan to prevent opioid addiction and enhance access to medication-assisted treatment.  APhA, in 
their response and effort to improve accessibility to patient care and public health, suggested that they “welcome the 
opportunity to work with HHS, CMS and Congress to develop alternative legislative solutions that utilize 
pharmacists to meet patients’ care needs, including those who need pain management and substance use disorder 
services.”  It is critical that agencies stay focused on this initiative and forge forward toward a solution together.  
(See Letter from Thomas E. Menighan, Executive Vice President and CEO of the American Pharmacists Association 
to the Center for Medicare & Medicaid Services 1 (Oct. 11, 2019) (on file with the author)). 
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prevent opioid misuse and overdose, and improve recovery from opioid addiction, among other 
components.86 As the HHS Secretary pointed out, “This historic investment by NIH was made 
possible by funding secured from Congress by President Trump and will support [the future ability 
to] ‘manage pain in an effective, personalized way.’”87  This initiative is called the Helping to End 
Addiction Long-Term Initiative (“NIH HEAL Initiative”).88 As part of the program, people 
suffering from chronic back pain will participate in a study on the effects of acupuncture on chronic 
back pain, and Medicare will cover the treatments for participants.89 
Francis S. Collins, M.D., Ph.D., the NIH director who created the initiative stated,  
It’s clear that a multi-pronged scientific approach is needed . . . and [t]his unprecedented 
investment in the NIH HEAL Initiative demonstrates the commitment to [reduce the risks 
of opioids, accelerate development of effective non-opioid therapies for pain and provide 
more flexible and effective options for treating addiction to opioids,] reversing this 
devastating crisis.  90   
“By the end of 2019, HHS will have awarded more than $9 billion in grants to states and local 
communities to help increase access to treatment and prevention services since the start of the 
 
86 Kaiser Health Network, NIH Awards $945M For Research On Treating Chronic Pain, Opioid Addiction, KAISER 
HEALTH NEWS (Sept. 27, 2019), https://khn.org/morning-breakout/nih-awards-945m-for-research-on-treating-
chronic-pain-opioid-addiction/. 
86 Press Release, U.S. Department of Health & Human Services, Trump Administration Announces $1.8 Billion in 
Funding to States to Continue Combating Opioid Crisis (Sept. 4, 2019), 
https://www.hhs.gov/about/news/2019/09/04/trump-administration-announces-1-8-billion-funding-states-
combating-opioid.html [hereinafter FUNDING TO STATES]. 
88 Press Release, NIH Office of the Director, NIH funds $945 million in research to tackle the national opioid crisis 
through NIH HEAL Initiative (Sept. 26, 2019), https://www.nih.gov/news-events/news-releases/nih-funds-945-
million-research-tackle-national-opioid-crisis-through-nih-heal-initiative [hereinafter NIH HEAL FUNDING]. 
89 Id. at 1. 
90 NIH HEAL FUNDING, supra note 87, at 1.  See also, Acute to Chronic Pain Signatures Program, 
https://heal.nih.gov/research/clinical-research/pain-signatures (last visited Nov. 21, 2019) (awarding $40 million 
previously to researchers to study 3,600 patients over two and a half years to find pain biomarkers and determine the 
biological, psychological and social factors that predict who is prone to developing chronic pain, with the goal of 
determining preventative treatment strategies). 
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Trump administration.”91 This is a significant improvement in funding for chronic pain.92 Efforts 
are underway to improve the treatment of chronic pain. 
C. The necessity of individualized, patient-centered multidisciplinary 
treatment plans  
Evidence-based therapies work well alone or as part of a multimodal treatment plan for 
chronic pain.93 These non-opioid therapies are safe and effective ways to reduce the need for 
opioids.94  Evidence-based alternative treatment methods are low risk, low cost, and accepted by 
patients, as discussed below.95  Many alternative treatments have been used successfully for 
thousands of years.96  Importantly, one modality may work for one pain condition but not others.97   
There is significant support for the notion that evidence-based alternative are lower risk 
than opioid therapies.98  The side effects are not potential drug dependency as with opioids, but 
instead have a reverse effect, helping to eliminate the need for opioids and reduce the dosage 
prescribed.99 Lower opioid use decreases both pharmacological side effects and the potential for 
addiction and abuse.100  For example, the NIH, as an agency deeply invested in human health 
 
91 FUNDING TO STATES, supra note 86, at 1.   
92 For comparison, in 2014, the NIH received $30 billion in taxpayer funds to improve health across the country and 
spent 95% less on chronic pain than it did on heart disease, cancer and diabetes.  Chronic pain funding at that time 
totaled approximately $402 million dollars.  See Chronic Pain Research Alliance Federal Investment in Pain 
Research, http://www.chronicpainresearch.org/Research (last visited Nov. 26, 2019). 
93 Heather Tick et al., Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain Care: The Consortium 
Pain Task Force White Paper, 14 EXPLORE 177, 187 (2018). 
94 Id. at 187. 
95 Syed A. Tabish, Complementary and Alternative Healthcare: Is it Evidence-based? 2 INT’L J. HEALTH SCI. 1, 1 
(2008). 
96 Id. at 1. 
97 TASK FORCE REPORT, supra note 80, at 32. 
98 See The Joint Commission Division of Healthcare Improvement, Non-pharmacologic and non-opioid solutions 
for pain management, 44 QUICK SAFETY 1, 1 (2018), 
https://www.jointcommission.org/assets/1/23/QS_Nonopioid_pain_mgmt_8_15_18_FINAL.pdf. 
99 Sun et al., supra note 59, at 6. 
100 Id. at 1. 
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outcomes, released the “NIH Consensus Statement on Acupuncture . . . in 1998[, stating,] ‘the 
incidence of adverse effects [from acupuncture] is substantially lower than that of many drugs or 
other accepted procedures for the same conditions.’”101   
In terms of cost-effectiveness, several economic analyses compared the costs and health 
effects between two or more pain therapies and showed more benefit for the economic investment 
in non-pharmacological evidence-based alternatives than opioids.102  For example, a review of 
cost-effectiveness of non-pharmacological alternatives for treating low back pain demonstrated 
that acupuncture was a cost-effective option; the paper reasoned that although individual 
acupuncture sessions costed more per session, the pain management benefits lasted for a longer 
duration than the three-month study, which overall led to a decrease in spending on treatment.103   
Although a study on the barriers to increased uptake of non-pharmacological treatment 
modalities pointed out a belief among patients that nonpharmacologic therapies are an additional 
expense104, an analysis of the scope of economic benefits changes this perception.105 Costs savings 
from use of evidence-based alternatives include outcomes such as “the avoidance of high tech 
conventional care, lower future healthcare utilization, and reduction of productive loss for 
employers.”106 The State of Washington performed a study that reported that insurance 
 
101 Tick et al., supra note 92, at 25 (citing NIH Consensus Conference, Acupuncture, 280 THE J. OF THE AM. MED. 
ASS’N 1518 (1998)). 
102 Patricia M. Herman, Evaluating the economics of complementary and integrative medicine, 2 GLOB. ADVANCES IN 
HEALTH AND MED. 56, 59 (2013). 
103 Lazaros Andronis et al., Cost-effectiveness of noninvasive and non-pharmacological interventions for low back 
pain: a systematic literature review, 15 APPLIED HEALTH ECON. & HEALTH POLICY 173, 173 (2017). 
104 William C. Becker et al., Barriers and facilitators to use of non-pharmacological treatments in chronic pain, 18 
BMC Family Practice 41 (2017). 
105 Herman, supra note 101, at 56. 
106 Id. at 56. 
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expenditures only modestly increased even when a significant number of insureds received non-
pharmacological therapies.107  This finding led to a follow-up study of state-insured patients with 
back pain, fibromyalgia and menopause symptoms, which showed lower overall insurance costs 
for people who used evidence-based alternatives versus those who did not.108  
A different study that looked at costs in an interdisciplinary pediatric pain clinic using 
acupuncture, biofeedback, psychotherapy and massage with medication showed decreased 
inpatient and emergency department visits.109  This resulted in an outstanding cost savings of 
$36,228 per patient per year in hospital costs and $11,482 per patient per year in insurance costs.110 
These cost analyses support the integration of an individualized interdisciplinary pain plan.  It also 
shows how accessibility to and participation in a pain clinic over one year can significantly reduce 
economic costs by more than the cost of the intervention itself.111 
Patients accept non-pharmacological alternatives.  A review that looked at education on 
and accessibility to non-pharmacological alternatives showed that seventy-five percent (75%) of 
patients who previously did not use evidence-based alternatives would utilize these treatments 
after gaining awareness of and accessibility to such therapies.112  This statistic came from a study 
of 103 Veterans in a Midwestern VA Medical Center that assessed whether Veterans would report 
 
107 William E. Lafferty et al., Insurance coverage and subsequent utilization of complementary and alternative 
medicine providers, 12 AM. J. OF MANAGED CARE 1,6 (2006).  
108 Bonnie K. Lind et al.,  Comparison of health care expenditures among insured users and nonusers of 
complementary and alternative medicine in Washington State: a cost minimization analysis, 16 J. ALT. & 
COMPLEMENTARY MED. 411, 414 (2010). 
109 Nicole E. Mahrer et al., A Cost-Analysis of an Interdisciplinary Pediatric Chronic Pain Clinic, 19 J. PAIN 158, 
163 (2018). 
110 Id. at 163. 
111 Id. at 164. 
112 David Cosio & Erica Lin, Effects of a Pain Education Program in Complementary & Alternative Medicine 
Treatment Utilization at a VA Medical Center, 23 COMPLEMENTARY THERAPIES IN MED., 413, 414 (2015). 
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an increase in evidence-based alternative utilization after completing a formal pain education 
program.113  The educational course took place 1-day-per-week for 12-weeks and introduced the 
Veterans and their families to twenty-three (23) different nonpharmacologic therapies for pain.114 
The results of the study demonstrated a significant increase in the overall utilization of evidence-
based alternatives by the Veterans after the education program.115  
Patients have better outcomes when they play an active role in their improvement.116  A 
study supported the literature suggesting that “when patients are partners in their own care, they 
have better outcomes and medication costs decrease.”117 When people reap the benefits of non-
pharmacological alternatives, they feel better, and they actively choose to practice them on their 
own.118  Resultantly, patients experience pain relief benefits that result in lower utilization of 
pharmacological medication.119 Importantly, and as suggested by the CDC’s 2016 prescribing 
guidelines commentary, clinicians need to weigh both the pros and cons of non-pharmacological 
alternatives based on the individual patient’s pain and gear the treatment plan toward the patient’s 
needs and goals.120  Although chronic pain patients organized over the last few years, claiming 
that opioids are the best treatment modality for chronic pain and that they should not be tapered 
 
113 Id. at 1. 
114 Id. at 1. 
115 Id. at 1. 
116 Mack A. Thomas, Pain Management – The Challenge, 5 PAIN MGMT. 15, 19 (2003). 
117 Cecilia Kaechele, Improving Patient Comfort with Nonpharmacologic Therapies, (Apr. 20, 2018) (unpublished 
thesis, East Carolina University) (on file with East Carolina ScholarShip Digital Archive),  
http://thescholarship.ecu.edu/bitstream/handle/10342/6667/Kaechele_Final.docx?sequence=1&isAllowed=y.  
118 Id. at 13. 
119 Kaechele, supra note 116, at 47 (citing Anna Jarrett et al., Nurses' knowledge and attitudes about pain in 
hospitalized patients, 27 CLINICAL NURSE SPECIALIST, 81 (2017) and Lori P. Montross-Thomas et al., Hospitalized 
patients' preferences, beliefs, and stated willingness to pay for complementary and alternative medicine treatments, 
23 J. ALT. & COMPLEMENTARY MED. 259 (2017). 
120 Mahrer et al., A Cost-Analysis of an Interdisciplinary Pediatric Chronic Pain Clinic, 19 J. PAIN, 158, 158 (2018). 
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off of prescription opioids, arguably, they vocalized their views because health care practitioners 
ignored their needs.  Practitioners did not utilize the CDC guidelines properly, and patients did not 
have ready access to non-opioid treatment methods.121  Resultantly, these patients sought relief.122 
A multidisciplinary approach is critical. A study on the efficacy of a multidisciplinary 
approach for treating chronic pain assessed the effects of a 15-week multidisciplinary treatment 
program for pain rehabilitation, specifically focusing on pain and the ability to function and 
perform activities.123  The program consisted of CBT and exercise, along with individual and group 
sessions that incorporated other treatment modalities.124  The program rated participants’ pain and 
assessed the patients’ pain over time.125  This 165 patient study showed statistically significant 
improvements for the subjects between admission and discharge.126 The study reinforces the theory 
that non-pharmacological alternatives work for chronic pain, and a multimodal approach is 
effective.127 A multidisciplinary, individualized approach to pain management is essential. 
D. Disparities due to non-existent overarching pain management framework 
and lack of insurance coverage 
1. Problems with a non-universal framework and gaps in coverage 
Current law lacks an overarching framework for insurance coverage of pain management 
techniques.  With the exception of a few individual states that pushed for the implementation of 
 
121 Jayne O’Donnell & Josephine Chu, Chronic pain patients, overlooked in opioid crisis, getting new attention from 
top at FDA, USA TODAY (Jul. 2, 2018), https://www.usatoday.com/story/news/politics/2018/07/02/chronic-pain-
patients-needs-ignored-opioid-epidemic/727015002/. 
122 Id. at 1. 
123 Robin Koele et al., Multidisciplinary rehabilitation for chronic widespread musculoskeletal pain: results from daily 
practice, 12 MUSCULOSKELETAL CARE 210, 210 (2014). 
124 Id. at 210. 
125 Id. at 210. 
126 Id. at 210. 
127 Id. at 210. 
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specific evidence-based alternatives through now enacted or pending bills (Georgia, 
Massachusetts, New York, and Rhode Island cover or may in the future cover chiropractic care, 
for example), steps taken did not resolve the larger problems with the approach to coverage for 
pain management.128  The current administration and federal agencies started dedicating 
significant funding toward pain management through its initiative to stop the opioid crisis, but now 
states through their medical boards which are responsible for regulating the practice of medicine, 
need to take control and handle pain management.129   
Hospitals, including VA medical centers, pushed for transparency in opioid 
administration.130  While these transparency measures certainly are steps in the right direction, it 
does not mean that the law should become so draconian and anti-opioid that people who need 
opioids are ultimately denied opioid treatment.131 Without a national framework, unintended 
disparities in access to evidence-based alternatives will inherently exist and persist. 
2. The status of insurance coverage: failure to cover and restrictions limiting 
accessibility 
In reflecting on the American College of Physicians (“ACP”) 2017 guidelines, scientists 
assessed the state of insurance coverage for non-pharmacological evidence-based alternatives.132  
The ACP guidelines recommended non-pharmacological alternatives for chronic low back pain.133 
 
128 See e.g., W. Va. Code § 16-54-8 (2018) (showing a state bill that passed and includes coverage for chiropractic 
care as treatment for pain).   
129 Drew Carlson & James M. Thompson, The Role of State Medical Boards, AMA J. OF ETHICS, 
https://journalofethics.ama-assn.org/article/role-state-medical-boards/2005-04 (last visited: Nov. 29, 2019). 
130 Roe, supra note 10, at 3. 
131 O’Donnell, supra note 120, at 2. 
132 Robert Bonakdar et al., Analysis of State Insurance Coverage for Nonpharmacologic Treatment of Low Back 
Pain as Recommended by the American College of Physicians Guidelines, 8 GLOB. ADVANCES IN HEALTH & MED. 
1, 2 (2019). 
133 Id. at 2. 
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The study looked at minimum required coverage and limitations and exclusions.134 In nearly all 
state-based coverage policies, chronic pain management and multidisciplinary rehabilitation were 
not addressed.135  Coverage was the highest for chiropractic care, in a total of 46 states.136  Less 
than ten states covered acupuncture, massage, and biofeedback.137 Insurance did not cover tai chi 
or yoga.138 Insurance accepted CBT often as mental health therapy, but excluded it for treating 
pain.139  The study shows that health care practitioners and facilities did not optimize the 
coordination of non-pharmacological care across disciplines, despite recommendations suggesting 
incorporation of non-pharmacologic alternatives.140 Insurance impeded efforts to utilize such 
treatment methods due to its restrictions and exclusions, despite the evidence base for these 
treatment methods.141 
E. Findings from brain imaging related to chronic pain and healing 
Brain imaging demonstrates that pain causes neural pathways to rewire in the brain and, as 
patients recover from pain, these pathway changes uncouple.142 A study on brain activity in chronic 
pain patient groups (chronic back pain, osteoarthritis, chronic pelvic pain, chronic post-herpetic 
neuralgia, chronic complex regional pain syndrome)—with either (i) spontaneous pain, (ii) pain 
due to a stimulus that does not normally provoke pain, or (iii) acute thermal mechanical stimuli—
 
134 Id. at 2. 
135 Id. at 5. 
136 Id. at 3. 
137 Id. at 5. 
138 Id. at 5. 
139 Id. at 6. 
140 Id. at 8. 
141 Id. at 3. 
142 David Borsook, Address at the Mass General Hospital Center for Law, Brain & Behavior Public Symposium: The 
Pain Brain in Evidence and Policy—Visible Solutions: How Neuroimaging Helps Law Re-Envision Pain (June 30, 
2015), 31:00-31:06. 
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found that each chronic pain condition evoked a brain activity pattern unique to the condition.143  
The study showed the presence of ongoing pain in different brain regions than acute pain, 
specifically regions more related to emotions and self-evaluation.144   
Tools to show the physical correlates of pain include EEG, MRI, and X-ray, for example.145 
As for pain diagnosis, there is no way to map how much pain a person is experiencing; there is no 
test to measure pain intensity, and no instrument can locate pain precisely.146 Chronic pain can 
cause a reduction in the brain’s gray-matter volume, presumably due to the effects of chronic 
stress.147 Neuroimaging studies demonstrated the reversal of such anatomical changes in the brain 
when effective CBT was part of the treatment regimen for chronic pain.148 
A forthcoming study focused on “overcoming chronic pain” involves a researcher’s use of 
a brain imaging study to determine the efficacy of a new mindbody approach for the treatment of 
chronic back pain.149  The study—performed at the University of Colorado Boulder between July 
and September 2019—involved 90 chronic back pain patients: “30 patients [were] treated with a 
mindbody approach, 30 patients . . . receive[d] a placebo injection, and another 30 patients . . . 
receive[d] no treatment at all.”150 All 90 patients underwent fMRI brain scans both before and after 
 
143 Marwan N. Baliki & A. Vania Apkarian, Nociception, pain, negative moods and behavior selection, 87 NEURON 
474, 485 (2015). 
144 Id. at 487. 
145 Debbie L Morton et al., Brain imaging of pain: state of the art, J. OF PAIN RESEARCH 613, 614 (2016) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019436/pdf/jpr-9-613.pdf. 
146 OWEN D. JONES ET AL., LAW AND NEUROSCIENCE 591 (2014).   
147 Muhammad Hassan Majeed & Donna M. Sudak, Cognitive Behavioral Therapy for Chronic Pain-One Therapeutic 
Approach for the Opioid Epidemic, 23 J. PSYCHIATRIC PRACTICE 409, 412 (2017). 
148 Id. at 412. 
149 Howard Schubiner, Breakthrough Study: Overcoming Chronic Pain, 
https://www.indiegogo.com/projects/breakthrough-study-overcoming-chronic-pain#/ (last visited Nov. 24, 2019). 
150 Id. at 1. 
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treatment to objectively assess the changes in pain for members of each group.151  The results have 
not been published yet.  This study shows that society is, contrary to the Carradine case mentioned 
earlier, recognizing that some forms of chronic pain are not caused by physical problems in the 
body, but rather through modified neural pathways in the brain.152 Just as the body learns pain and 
the brain forms new synaptic profiles, when pain relief and renormalization of cognitive abilities 
occur, gray matter can increase and the disease can reverse.153   
III. SOLUTION—LEGAL REFORM: BRIDGING THE GAP THROUGH A 
MANDATORY EVIDENCE-BASED TREATMENT PLAN IN PLACE OF 
OPIOIDS (OR IN CONJUNCTION WITH OPIOIDS WHERE MEDICALLY 
NECESSARY) 
A. Provision of chronic pain-related HHS funding to state medical boards 
contingent upon implementation of evidence-based alternative treatment 
plans  
There are gaps in the protocol for treating chronic pain, and the law needs to make access 
to alternatives a priority. The proposed course of action is implementation of a mandatory 
evidence-based treatment plan in place of opioid therapy or, where medically necessary, in 
conjunction with prescription opioids.  HHS should mandate alternative treatment as a component 
of chronic pain management. In order to avoid Tenth Amendment issues and running afoul of the 
Constitutional delegation of the right to regulate the practice of medicine to the states, HHS should 
condition future chronic pain funding to the states in connection with the initiative to stop the 
 
151 Id. at 1. 
152 Id. at 1. 
153 Id. at 1.  See also A. Vania Apkarian, The Brain in Chronic Pain: Clinical Implications, 1 PAIN MANAGEMENT 577 
(2011), in JONES ET AL., supra note 1, at 348.   
Stephanie Flackman 
Time of Submission: 12/6/2019 at 12:50PM 
 
 
 
26 
 
 
opioid crisis, on each state’s compliance with an mandatory evidence-based treatment plan 
program.154 Under the U.S. Constitution, 
[A]lthough the states have ceded the power to regulate interstate commerce to the federal 
government, they retained, via their police powers, the right to regulate any activity that 
poses a threat to the public health or safety of their citizens. Thus, state laws that seek to 
ban the import of milk from outside the state to protect local dairies are an unconstitutional 
attempt to control trade. In contrast, state laws that focus on consumer protection, such as 
requiring the sanitary inspection of imported milk and banning the import of contaminated 
milk, are constitutional, provided they also apply to milk produced within the state. This 
distinction between laws affecting commerce and laws affecting health and safety is 
important to medical care practitioners because the regulation of the practice of medicine 
is considered a health and safety issue and thus reserved to the states as a police power.155 
 
HHS contingent funding and resources should make an impact immediately to effectuate the 
required multidisciplinary non-pharmacological treatment plan for patients with chronic pain 
discussed in this paper. As part of this initiative, the state medical boards should require doctors 
to develop compliant treatment plans, and when practitioners are compliant, the state medical 
board becomes eligible for the funding from HHS.  
The protocol that practitioners need to implement for their states to be eligible for HHS 
funding must ensure that the patient treatment plan is individualized, specific to each patient’s 
needs and goals, and integrates some combination of non-pharmacological, evidence-based 
treatment alternatives, such as cognitive behavioral therapy, acupuncture, or physical therapy.  A 
patient’s plan could incorporate telehealth and telemedicine if mobility is an impediment to 
 
154 See U.S. CONST. amend. X (reserving “the powers not delegated to the United States by the Constitution, nor 
prohibited by it to the States, . . . to the States respectively, or to the people.”). 
155 Edward Richards, State versus Federal Powers- The Regulation of Commerce, THE LSU MEDICAL AND PUBLIC 
HEALTH LAW SITE 1, 1 (2009) (referencing Dean Milk Co. v. Madison, 340 U.S. 349 (1951)).   
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attending treatment sessions.  The protocol also should mandate a 15-week treatment plan for 
patients that incorporates the treatment methodologies the patient needs to realize positive changes 
in health outcomes.  The patients who need opioids visit their health care providers regularly to 
discuss their status regardless, in order to receive new prescriptions. Those visits should include 
provider inquiries about patient attendance at their mandated treatment plan sessions where 
providers evaluate the individual’s plan and make adjustments as necessary.   
B. Required Insurance Coverage 
Additionally, HHS should ramp up Medicare and Medicaid reimbursement for alternative 
pain therapies. Insurance companies need to cover these alternatives. Analogous to the withholding 
of funding in South Dakota v. Dole, it is up to the states to follow the protocol here.156  If a state 
elects to participate in this program, that state will receive enhanced reimbursement for providing 
evidence-based alternatives, and as a condition of receiving the bolstered reimbursement funding, 
the state will need to comply with HHS’s rules for the program. Since the Center for Medicare and 
Medicaid Services (CMS) falls under the operating divisions of HHS, HHS and CMS should work 
together on this effort.157  HHS would then provide reimbursement.158   
 
156 See generally South Dakota v. Dole,  483 U.S. 203 (1987) (withholding a percentage of highway funding from 
states that failed to raise the drinking age to 21). 
157 Assistant Secretary for Public Affairs, HHS Organizational Chart, U.S. DEPARTMENT OF HEALTH & HUMAN 
SERVICES (Nov.14, 2018), https://www.hhs.gov/about/agencies/orgchart/index.html.  
158 NFIB v. Sebelius, 567 U.S. 519 (2012) also sheds light on how to implement this program. The Supreme Court, 
in reviewing the Medicaid expansion provision of Patient Protection and Affordable Care Act of 2010 found that the 
conditions on federal funding in that case exceeded Congress’s spending power because it was impermissibly 
coercive and otherwise intruded on the role of the states in the federalist system and the delegation of the power over 
medicine to the states.  The court’s reasoning included that Congress can tell states that accept funding how to 
comply but cannot penalize states that do not comply by taking away all Medicaid funding.  This is distinguishable 
from this program, because this is a supplemental reimbursement program for states that provide access to 
alternatives, separate and distinct from the current Medicare and Medicaid framework. 
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HHS’s Pain Management Best Practices Inter-Agency Task Force, in its Task Force 
Report, made some relevant recommendations related to this paper.159  The Task Force 
recommended that CMS and private payers implement improved payment models that cover 
integrated, multidisciplinary pain management, including CBT.160  This model indicated that CMS 
and private payers should specifically provide reimbursement for pain management consistent with 
the time and resources dedicated to educating and evaluating the patient (including risk for 
misuse), re-evaluating the patient after initiating treatment, and integrating evidence-based non-
pharmacological alternatives to opioid therapy.161  CMS and private payers should also align their 
reimbursement guidelines for chronic multidisciplinary pain management with current clinical 
practice guidelines.162  Additionally, payers need to provide reimbursement for non-opioid 
pharmacologic therapies that are more expensive than opioids, such as long-acting local anesthetic 
injections and infusions and intravenous acetaminophen analgesia, because as discussed 
previously, there are longer-term economic benefits of providing this coverage.163  With a 
contingent funding mechanism, CMS and private payers will cover evidence-based alternatives. 
C. The Pain Management Team Model 
Crucial to the success of this proposal, the individualized, multidisciplinary treatment plans 
for chronic pain management require organization through a team of specialists.164 This is a best 
practice, yet the current reimbursement models are barriers to providing this type of treatment.165 
 
159 See generally TASK FORCE REPORT, supra note 80, at 1-116.  
160 Id. at 46. 
161 Id. at 51. 
162 Id. at 71. 
163 Id. at 71. 
164 Id. at 62. 
165 Id. at 40. 
Stephanie Flackman 
Time of Submission: 12/6/2019 at 12:50PM 
 
 
 
29 
 
 
Payers should follow a chronic disease management model for reimbursement and should include 
reimbursement for multidisciplinary pain care similar to that used for cardiac rehabilitation and 
diabetes programs.166 In addition, the reimbursement should cover the time teams spend 
coordinating patient care.167  The Task Force also recommends development of a CPT code for 
pain care coordination and conferences.168 There should be a telehealth option for reimbursing 
pain management to facilitate access in underserved locations that payers cover as well.169 
The law should necessitate that insurance companies cover all of the evidence-based 
alternatives that the doctor recommends for the patient, as mentioned above. Additionally, as part 
of the program, patients with chronic pain could use an identification card that allows them to 
attend unlimited sessions of group evidence-based alternative treatment sessions to supplement the 
mandated plan that the patient follows.  HHS should post the locations that offer group medical 
treatments for chronic pain and make the services free to participants, as long as they sign up in 
advance—by phone or through the website—so the health care provider location can have the 
appropriate medical staff on site to provide the service.  HHS, through the states, should provide 
these service providers with a stipend for the cost of having the necessary medically trained 
personnel conduct the sessions. HHS, as part of its contingent funding program, can withhold this 
funding unless states make the evidence-based alternative treatment plans mandatory. 
 
 
 
166 Id. at 71. 
167 Id. at 71. 
168 Id. at 71. 
169 Id. at 71. 
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D. Reasoning for 15-Week Program Length  
This paper derived the calculation of a 15-week mandated program based on the results of 
the studies discussed earlier in this paper. The 15-week program mentioned previously showed 
statistically significant changes in patient outcomes attributable to their multidisciplinary treatment 
plan.170  A CBT study showed that after 11 weeks of CBT, patients with chronic pain had healthier 
gray-matter volumes in their brains.171 The physical therapy study showed improvements over 5 
to 8 sessions.172 The acupuncture study showed changes in patients over 12 weeks.173  Fifteen 
weeks seems like a prudent determination of a meaningful duration to start to create improved 
health outcomes for patients with chronic pain.  The plan should allow for extension as needed, 
depending on the patient’s results and need for more therapy. 
This proposal, while unique insofar as it is mandatory, is not novel in its elements or 
approach.  A Position Statement from the American Academy of Pain Medicine, which discussed 
Minimum Insurance Benefits for Patients with Chronic Pain, proposed a framework on March 7, 
2014 with regard to insurance coverage.174  The proposal targeted the treatment of pain that is not 
expected to resolve in the near future and that is not responsive to other treatments.175 The coverage 
framework included (i) Medical management; (ii) Evidence- or consensus-based 
interventional/procedural therapies; (iii) Ongoing behavioral/psychological/psychiatric therapies; 
(iv) Interdisciplinary care; and (v) Evidence-based complementary and integrative medicine (e.g., 
 
170 Koele, supra note 122, at 210. 
171 Seminowicz, supra note 49, at 10. 
172 Sun, supra note 59, at 5. 
173 MacPherson & Vertosick, supra note 69, at 5. 
174 Position Statement, American Academy of Pain Medicine, Use of Opioids for the Treatment of Chronic Pain (Mar. 
7, 2013), https://painmed.org/about/position-statements/use-of-opioids-for-the-treatment-of-chronic-pain. 
175 Id. at 3. 
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yoga, massage therapy, acupuncture, manipulation).176 The American Academy of Pain Medicine 
suggested comparable coverage to the level of treatment coverage for people with mental-health 
disorders, and, similar to this paper, argued that limited visits and other restrictions including 
limited reimbursement are not appropriate for patients with unremitting pain.177 The proposed 
mandated program of a 15-week multidisciplinary treatment plan for chronic pain patients will 
benefit people suffering from the disease of chronic pain.   
IV. ADDRESSING THE RESISTANCE TO CHANGE 
Doctors and patients voiced concerns about the “cost” of chronic pain management, and 
this section addresses those concerns. The arguments include higher costs and impracticability of 
spending time on alternatives, as well as requiring insurance companies to cover unprecedented 
treatment options.178 The media, some studies, and other publications echoed these concerns.179   
In a study that interviewed primary care providers regarding treating co-morbid chronic 
pain and opioid use disorder, the doctors reported that barriers to implementing alternatives include 
lack of resources like staff, time, and access to alternatives.180  Regarding the barrier of time, the 
PCPs explained that they do not have the time to spend working with patients on alternative 
treatment plans.181 A separate study by Lauren S. Penney and her team on provider and patient 
perspectives regarding alternatives to opioids for managing chronic pain, quotes a primary care 
 
176 Id. at 1. 
177 Allyson Varley et al., Assessing Barriers and Facilitators to the Uptake of Best Practices for threating Co-
Occurring Chronic Pain and Opioid Use Disorder, Poster at the 11th Annual Conference on the Science of 
Dissemination and Implementation in Health (December 3-5, 2018). 
178 Id. at 1. 
179 Lauren S. Penney et al., Provider and patient perspectives on opioids and alternative treatments for managing 
chronic pain: a qualitative study, 17 BMC FAMILY PRACTICE 164, 170 (2016). 
180 Varley, supra note 176, at 1. 
181 Penney et al., supra note 178, at 171. 
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physician, who sheds light on this perspective, “We get our little ten-minute[s] per patient, which 
is so grossly, woefully an inadequate amount of time to see a patient. Ten minutes, right, for all 
your problems. And so nobody wants to take the time to explore things other than drugs for people 
with chronic pain.”182  This is problematic and is an issue that HHS contingent funding can address, 
especially if it compensates health care providers for the time spent implementing non-
pharmacological alternatives and coordinating care among various service providers. 
The aforementioned study from 2007, which discussed efficacy of alternative pain 
treatments flagged some duplicative issues and some different concerns relevant to the difficulties 
for practitioners making decisions about using or incorporating alternatives, including the 
following:  
additional time and energy investments, the need for specially trained personnel to 
administer the modalities, known or potential side effects, safety in combining alternatives 
and other modalities, likely acceptance by clients and the public (and hence the issue of 
long-term adherence), and ease of incorporation into traditional pain management 
practices.183   
Another argument against the implementation of the proposed multidisciplinary, individualized 
evidence-based alternative plans for chronic pain patients is the contention that insurance 
companies will need to expend (potentially substantial) money on alternative treatments that they 
have failed to previously cover.184   
 
182 Id. at 174. 
183 Tan et al., supra note 38, at 210. 
184 Tracey Walker, Study Reveals Insurers Could Do More to Cover Opioid Alternatives, MANAGED HEALTH CARE 
EXEC. (Oct. 14, 2018), https://www.managedhealthcareexecutive.com/pharma-forecast-report/study-reveals-insurers-
could-do-more-cover-opioid-alternatives. 
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 These critiques beg the question: How can we assess whether these concerns are legitimate 
if we have never truly attempted to incorporate these alternatives? This paper argues that quick 
fixes with opioids alone have failed to solve problems for people with chronic pain, and the need 
for integration of non-pharmacological, evidence-based alternatives is critical to helping these 
patients. Chronic pain costs our country because people are suffering and dying from misuse of 
opioids.185  The cost of alternative treatments cannot truly be assessed without attempting to 
effectively implement a program to fill the known gaps in chronic pain treatment.  
To put this in perspective, Professor Jennifer Oliva, who specializes in health law and is 
following the opioid crisis closely, pointed out that monetarily, “the cost of the opioid crisis 
exceeds $1 trillion dollars and is rising every day already.”186  These extravagant costs demand a 
new approach to try to fix this problem. Professor Oliva also pointed out that “by certain 
projections, the crisis will continue to get worse before it gets better, meaning that it is critical to 
implement evidence-based alternatives as soon as possible.”187   
Chronic pain costs the United States $560 to $635 billion annually, according to the 
National Academy of Medicine.188  This cost is higher than the nation’s annual expenditures for 
 
185 NATIONAL INSTITUTE ON DRUG ABUSE, supra note 12, at 1. 
186  Greg Allen, Cost Of U.S. Opioid Epidemic Since 2001 Is $1 Trillion And Climbing, NPR (Feb. 13, 2018 6:00 AM), 
https://www.npr.org/sections/health-shots/2018/02/13/585199746/cost-of-u-s-opioid-epidemic-since-2001-is-1-
trillion-and-climbing. 
187 German Lopez, How America’s opioid epidemic could get even worse, VOX (Aug. 29, 2019, 1:00 PM), 
https://www.vox.com/policy-and-politics/2019/8/29/20836719/opioid-epidemic-fentanyl-rand-report. 
188 Darrell J. Gaskin & Patrick Richard, The economic costs of pain in the United States,  13 J. PAIN 715, 723 (2012) 
(citing IOM REPORT). 
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heart disease, cancer, and diabetes combined.189 “We can expect the chronic pain burden to 
escalate,”190 especially as chronic illnesses increase over time.  
This paper takes the position that “most of the nonpharmacologic strategies are 
underutilized due to lack of evidence dissemination, education, and reimbursement. It is time for 
civilian medicine to join the call to action of military medicine outlined by Schoomaker and 
Buckenmaier.191 They urge the immediate incorporation of nonpharmacological evidence-based 
alternatives and active self-care, due to their safety, efficacy, and acceptance by patients.192 Their 
call to action aims to increase awareness, access, and utilization of nonpharmacologic treatments 
through education of practitioners and patients; to disseminate and reimburse evidence-based 
treatment options; and to promote ongoing research focused on the therapeutic and economic 
impact, in the short and long term, of comprehensive care practices.193  Importantly,  
[t]here is an additional benefit to many nonpharmacological pain care strategies; unlike 
drugs and surgery, the [evidence-based alternatives] involve patient participation and a 
commitment to self-care. Increased self-efficacy in managing pain correlates with 
improved mood and predicts improved outcomes in many chronic conditions, including 
pain.  For example, the military has studied ‘active self-care therapies’ as a category of 
pain management that may be of value in an integrated, multimodal approach.194   
Patients can perform many of these therapies on their own, reaping the ongoing benefits, cost free, 
as they apply the therapies and techniques in their everyday lives.195  An individual can practice 
 
189 Gaskin & Richard, supra note 187, at 715. 
190 Tick et al., supra note 92, at 179. 
191 Id. at 197. 
192 Schoomaker & Buckenmaier, supra note 40 at 2. 
193 Tick et al., supra note 92, at 197. 
194 Id. at 187.   
195 Anne Kennedy et al., Support for self care for patients with chronic disease, 335 BRITISH MED. J. 1, 3 (2007), 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2071971/. 
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the CBT coping skills on their own and perform exercises on their own, for example, causing 
accelerated healing rates because of the added benefits achieved between sessions.196 
Medicine and policy decision-making professionals acknowledge the crisis in pain and pain 
care.197  “If we could find a way of intervening, . . . then the . . . need [for] opioids or heavy doses 
of analgesics will diminish.”198 Through an effective legislative framework, a solution can be 
found.  As mentioned earlier and worth repeating, “[i]nstead of symptom management, we would 
be managing the disease.”199 
CONCLUSION 
People suffering from the disease of chronic pain need a mandatory program that 
incorporates evidence-based alternatives in place of, or if medically necessary, in conjunction with, 
the prescribing of opioids. Since states are responsible for regulating the practice of medicine, 
HHS should condition state funding for chronic pain, provided in connection with the funding for 
the opioid crisis, on each state’s implementation of mandatory alternative treatment programs.  
HHS should similarly set up a program for supplemental insurance reimbursement for provision 
of these evidence-based alternatives.  This contingent funding will boost integration of effective 
pain management techniques, help mitigate the deadly and costly opioid epidemic, and create 
longer sustaining benefits for chronic pain management. 
 
196 Cleveland Clinic, CHRONIC PAIN MANAGEMENT AND TREATMENT, 
https://my.clevelandclinic.org/health/diseases/4798-chronic-pain/management-and-treatment (last visited Nov. 26, 
2019). 
197 Bernstein, supra note 1, at 5. 
198 Id. at 5. 
199 Id. at 5. 
